Bacteria Break Cell Barriers by Moving Their Fasteners, Not Destroying Them
Experiments in a laboratory model and mice identify a host protein that helps pull cell connections apart. The finding gives researchers a possible target for protecting barriers against infection.
Researchers have identified a molecular route through which bacterial exposure weakens protective cell barriers, opening a possible path to preserving the body's defences during infection. [2]
In laboratory experiments and mice, a protein called FOXO1 moved into the cell nucleus after bacterial exposure. Proteins that help fasten neighbouring cells together then shifted away from the cell surface, leaving the barrier more permeable. Changing where FOXO1 could go, or removing it from the relevant cells, altered that response. [2]
The work, led by Stella Alimperti of Georgetown University and Dana T. Graves of the University of Pennsylvania, was published in Nature Communications on November 6, 2026. The journal identifies it as peer-reviewed accepted research released before final copy editing. [2]
Epithelial cells form sheets lining surfaces including the mouth, gut and lungs. Their connections help keep microbes from reaching deeper tissues. The study identifies a way those connections can fail even when the proteins holding them together have not been destroyed. [2]
Graves said bacteria can move the cell-joining machinery rather than destroy it. That makes the location of the proteins central to understanding how the barrier breaks down. [1][3]
The fasteners move
The researchers focused on two proteins, E-cadherin and β-catenin, that work together at the cell membrane to help maintain connections between epithelial cells. Following bacterial exposure, both shifted towards the cell interior and their association was disrupted. The barrier became leakier. [2]
A connection needs its parts in the right place. Having the proteins somewhere inside a cell does not preserve the junction they were helping to hold together at its edge. The study therefore directs attention to the movement of existing proteins, rather than simply how much of each protein a cell contains. [2]
FOXO1 belongs to the host cell, not the bacterium. The researchers found that exposure to bacteria or lipopolysaccharide, a bacterial component, moved FOXO1 into the nucleus, the compartment containing the cell's DNA. That movement was associated with the rearrangement of the joining proteins. [2]
The reported effect did not depend on gene transcription, the process of copying instructions from DNA, or on the breakdown of the joining proteins. The cell was shifting existing machinery away from its working position. [1][2]
The team also detected more binding between FOXO1 and β-catenin. Alongside that, β-catenin acquired more of a chemical modification at a particular site, Tyr654, as its association with E-cadherin was disrupted. These findings connect FOXO1's movement with changes in the machinery at the junction. [2]
Testing the driver
Watching proteins move together would establish an association. The researchers went further by changing FOXO1 itself and testing what happened to the barrier. [2]
They used a three-dimensional microfluidic device, a laboratory system that allows experiments with cells and controlled fluid flows, as well as a mouse model. Keeping FOXO1 in the nucleus could reproduce barrier failure. Keeping it in the cytoplasm, the part of the cell outside the nucleus, protected barrier function during bacterial challenge. [2]
Deleting the Foxo1 gene specifically in epithelial cells also protected the barrier during bacterial challenge. That targeted experiment strengthened the case that FOXO1 in the barrier cells helps drive the effect, rather than merely moving in response to damage caused elsewhere. [2]
The experiments provide a stronger basis for pursuing this pathway than observation alone would. Researchers could induce the failure by controlling FOXO1's location, and protect against it by preventing that response. That is the study's central advance. [2]
The evidence comes from the laboratory device and mice, not people, and the published abstract does not give animal or experimental sample counts. The work does not establish how many bacterial species trigger the pathway, show a safe or effective treatment, or test whether targeting FOXO1 would avoid antibiotic resistance. [2]
A possible target in the host
The finding gives future drug research a different starting point: a response inside the host cell that makes a protective barrier vulnerable. Preserving that barrier could be worth investigating alongside approaches directed at bacteria themselves. That is a research proposition, not a treatment result.
A useful intervention would have to control the damaging FOXO1 response while preserving the protein's normal functions. The experimental manipulations identify something to investigate, but a drug would need to achieve useful protection safely. [2][3]
The mouth gives that question a concrete setting. Graves described it as a gateway through which bacteria may reach the bloodstream when its barrier breaks down. He linked bacteria entering the bloodstream from the mouth with rheumatoid arthritis flare-ups, and cited reported links between oral bacteria and higher blood glucose, worsened dementia and cardiovascular disease. Those are broader associations he described, rather than diseases this experiment showed the FOXO1 pathway causes. [1][3]
The study grew from a three-year collaboration between Penn Dental Medicine and Georgetown. It received support from National Institutes of Health grants, the Toulmin Pilot Award and Georgetown startup funds. The authors declared no competing interests. [2][3]
The next research questions are practical: which bacterial signals trigger FOXO1's movement, how widely the pathway operates across different barriers, and whether an intervention can preserve those barriers safely. Establishing its role in people would then give researchers a basis for testing whether controlling it improves health. [2][3]
Every edition in brief, three times a day, on our Telegram channel, on Bluesky and on Threads.
Spotted an error? Tell the editors
- Hidden 'master switch' allows bacteria to breach the body's defenses Phys.org
- Non-canonical FOXO1 signaling governs epithelial barrier integrity through spatial regulation of the E-cadherin-β-catenin complex | Nature Communications nature.com
- Penn Dental Medicine Scientists Discover Hidden "Master Switch" That Allows Bacteria to Breach the Body's Defenses - Penn Dental Medicine dental.upenn.edu




